In colorectal cancer, the m6A modification pattern correlates with tumor mutational burden and reveals a link through which m6A, by associating with PIK3CA mutations, participates in regulating the cancer immune microenvironment and therapeutic response (53). This evidence concerns the gene PIK3CA and neoplasm.